FDA Investigator Albert A Salvador

Albert A Salvador has inspections in 1 countries as of 14 Nov 2023. Albert A Salvador has collaborated with a combinined 3335 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
84
Last Inspection Date:
14 Nov 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America
Co-Investigator(s):
Ana Delp Cintron, Ana P Barido, Anastasia I Onuorah, Anastasia M Shields, Andrea H Norwood, Angela E Glenn, Ann Marie Montemurro, Annette Melendez, Ashley A Segura, Ashley B Jelonek, Audrey Thereset Uy, Barbara D Wright, Barbara T Carmichael, Ben Du, Betsy C Galliher, Bonita S Chester, Brandon J Brookens, Brandy N Lepage, Brant M Schroeder, Brian D Young, Brunilda Torres, CDR Ileana Barreto Pettit, CDR Michael J Mero, CDR Sean T Creighton, Charles S Watson, Christian D Lynch (CDL), Christina K Theodorou, Christina Theodorou, Christopher Bastedo, Christopher T Smith, Clara E Santiago, Colleen M Aspinwall, Courtney A Gilbert, Courtney A Hunt, Craig A Garmendia, Craig D Zagata, Cynthia White, Daniel T Lee, Daniel W Johnson, Darlene C Plank Turlington, David J Hafner, Deborah A Racioppi, Debra L Pagano, Denise M Digiulio, Diana L Kelsch, Dianiris C Ayala, Dionne D Arline, Edward D Mcdonald, Edward H Maticka, Edwards, Erika M Wilkerson, Ernest L Levins, Ethan P Stegman, Gayle S Lawson, Gerald W Kopp, German Rivera, Glenn S Quintanilla, Hala L Selby, Harry R Bringger, Jr, Holly M Scott, Hunt, Israel Juarbe, Ivan E Reyes, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, James P Mcevoy, James To Neal, Jana L Caylor, Jason D Tenney, Jason P Aun, Jeannie R Mayberry, Jennifer Lalama, Jessica L Pressley, Joanne E King, John B Crowe, Jolanna A Norton, Jose R Rodriguez, Jose Velez, Joseph L Despins, PhD, Joseph S Fanelli, Joseph T Dougherty, Joshua J Silvestri, Judith A Paterson, Julianne C Mccullough, Karissa J Mccaw, Karyn M Campbell, Kelly I Anderson, Kelly N Kerr, Kendra L Brooks, Kimberly A Dux, Kristen D Evans, Kristina J Donohue, Kyle S Hobson, Laura E Garcia, LCDR Angelica M Chica, LCDR Randall L Morris, Leo J Lagrotte, Leslie A Cartmill, Linda K Matheny, Linda M Hoover, Lisa A Warner, Lisa B Orr, Lisa K Capron, LT John M Mastalski, LT Kimberly M Hull, LT Tamara J Henderson, LTJG Bradley E Benasutti, Madelyn Renteria, Magda M Karlsen, Marc A Jackson, Jr, Marcelo O Mangalindan, Jr, Martha Sullivan Myrick, Mary F Bodick, Matthew B Thomaston, Matthew R Noonan, Maureen A Wentzel, Melissa J Hill, Mendoza, Meredith L Sheridan, Meredith M Cobb, Michael A Taylor, Michael D Omeara, Michael J Nerz, Michelle S Dunaway, Miguel A Martinez, Mihaly S Ligmond, Mike M Rashti, Munoz, Murthy Vkn Sikha, Nicole E Knowlton, Nicole M Bell, Nikisha M Bolden, Ormond, Paul A Licata, Rachel A Peters, Raffi B Papazian, Raymond A Lyn, Jr, Richard K Vogel, Robert B Shibuya, MD, Robert J Maffei, Robert W Calais, Ronald T Colucci, Ronald T Weber, Ronnie E Jackson, Salvatore N Randazzo, Samantha J Pinizzotto, D V M, Sean D Duke, Seng Ching Hwang, Sergio E Delgado, Sharon Giamberini, Shavon L Square, Shelley L Waring, Sherbet L Samuels, Sheri L Stephenson, Sidney B Priesmeyer, Sonia M Monges, Stacey F Allard, Stacey F Rivette, State Agency, Stephanie C Milan, Stephanie Mangigian, MS/OSH, RN, Steven A Brettler, Steven L Carter, Susan F Laska, MS, Susan M Corrales, Susan M Jackson, Susan M Turcovski, Tania E Vizcaino, Tekalign Wondimu, Teresa I Navas, Teresa M Hillebrandt, Thai D Truong, Thomas E Friel, Thomas R Withers, Todd J Maushart, Tonya O Corbin, Valerie J Grecek Trinh, Van Cliff, Vernon L O'neil, Vlada Matusovsky, Wayne E Seifert, Wayne L Jefferson, Wayne T Smith, Whitney S Reynolds, Woody, Yessika Mashinski

Albert A Salvador's Documents

Publish Date Document Type Title
August, 2007 FDA 483 Perrigo Florida Inc - Form 483, 2007-08-02
June, 2003 FDA 483 Response Gino J. Sedillo, M.D. - Form 483R, 2003-07-01
June, 2003 EIR Gino J. Sedillo, M.D. - EIR, 2003-06-13
December, 2002 EIR Frank A. Lopez, M.D. - EIR, 2002-12-16
December, 2002 FDA 483 Frank A. Lopez, M.D. - Form 483, 2002-12-16
June, 2003 FDA 483 Gino J. Sedillo, M.D. - Form 483, 2003-06-20

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more